[HTML] sciencedirect.com

[HTML][HTML] Role of TLR4/MyD88/NF-κB signaling pathway in coronary microembolization-induced myocardial injury prevented and treated with nicorandil

Q Su, X Lv, Y Sun, Z Ye, B Kong, Z Qin - Biomedicine & Pharmacotherapy, 2018 - Elsevier
Coronary microembolization (CME) is a common complication during the treatment of acute
coronary syndrome (ACS) and percutaneous coronary intervention (PCI). Nicorandil can be …
被引用次数：62 相关文章

Role of TLR4/MyD88/NF-κB signaling pathway in coronary microembolization-induced myocardial injury prevented and treated with nicorandil

Q Su, X Lv, Y Sun, Z Ye, B Kong, Z Qin - Biomedicine & …, 2018 - hero.epa.gov
Coronary microembolization (CME) is a common complication during the treatment of acute
coronary syndrome (ACS) and percutaneous coronary intervention (PCI). Nicorandil can be …

Role of TLR4/MyD88/NF-κB signaling pathway in coronary microembolization-induced myocardial injury prevented and treated with nicorandil

Q Su, X Lv, Y Sun, Z Ye, B Kong… - Biomedicine & …, 2018 - pubmed.ncbi.nlm.nih.gov
Coronary microembolization (CME) is a common complication during the treatment of acute
coronary syndrome (ACS) and percutaneous coronary intervention (PCI). Nicorandil can be …

Role of TLR4/MyD88/NF-κB signaling pathway in coronary microembolization-induced myocardial injury prevented and treated with nicorandil.

Q Su, X Lv, Y Sun, Z Ye, B Kong… - Biomedicine & …, 2018 - europepmc.org
Coronary microembolization (CME) is a common complication during the treatment of acute
coronary syndrome (ACS) and percutaneous coronary intervention (PCI). Nicorandil can be …